23andMe Holding Co (ME)
4.75
+0.03
(+0.64%)
USD |
NASDAQ |
Nov 05, 16:00
4.72
-0.03
(-0.63%)
After-Hours: 19:06
23andMe Shareholders Equity (Quarterly): 143.50M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 143.50M |
| March 31, 2024 | 188.52M |
| December 31, 2023 | 377.19M |
| September 30, 2023 | 625.25M |
| June 30, 2023 | 675.49M |
| March 31, 2023 | 713.94M |
| December 31, 2022 | 750.99M |
| Date | Value |
|---|---|
| September 30, 2022 | 819.32M |
| June 30, 2022 | 854.20M |
| March 31, 2022 | 915.66M |
| December 31, 2021 | 961.17M |
| September 30, 2021 | 659.51M |
| June 30, 2021 | 662.54M |
| March 31, 2021 | -595.62M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-595.62M
Minimum
Mar 2021
961.17M
Maximum
Dec 2021
553.69M
Average
669.02M
Median
Shareholders Equity (Quarterly) Benchmarks
| RadNet Inc | 880.97M |
| iSpecimen Inc | 6.089M |
| Delcath Systems Inc | 4.192M |
| CytoSorbents Corp | 16.74M |
| Progyny Inc | 456.19M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.05M |
| Total Liabilities (Quarterly) | 224.54M |
| Current Ratio | 1.524 |